We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Evaluation of interleukin-33 and osteopontin levels in well and poorly regulated diabetes mellitus type 2.
- Authors
Ozdemir, Ozlem; Noyan, Tevfik; Uner, Abdullah; Akalin, Cagri
- Abstract
IL-33 is one of the novel IL-1 family members which are secreted in many tissues. Osteopontin (OPN) is a highly phosphorylated and glycosylated sialoprotein synthesized primarily in bone tissue, which the major role is to participate in biomineralization. Both IL-33 and OPN are mentioned associated with inflammatory disorders. Diabetes Mellitus Type 2 (T2DM) is a metabolic disorder in glucose homeostasis, which its pathophysiology involves a low-grade chronic inflammation. The aim of this study is to evaluate the IL-33 and OPN levels in well and poorly regulated T2DM patients. Three group were determined as; T2DM with HbA1c level below 8% as Group HbA1c <8, T2DM with HbA1c level of 8% and above as Group HbA1c ≥8, and control group consisting of healthy individuals respectively. Each group included 50 participant (n=50). Age, fasting plasma glucose, HbA1c and lipid parameters (total cholesterol, triglyceride, LDL, HDL), IL-33 and OPN values were examined. There was a significant statistical difference between the fasting plasma glucose, HbA1c, triglyceride, and HDL levels of the groups (p<0.001). OPN levels of the groups were not found statistically different but IL-33 levels were found to be significantly higher in the HbA1c <8 group compared to the control group (p=0.0108). IL-33 and OPN levels do not differ in terms of well or poorly regulation in T2DM patients and HbA1c level alone, is insufficient to be a predictor of OPN and IL-33 activity
- Subjects
INTERLEUKIN-33; OSTEOPONTIN; TYPE 2 diabetes; BIOMINERALIZATION; PATHOLOGICAL physiology; METABOLIC disorders
- Publication
Medicine Science, 2024, Vol 13, Issue 2, p315
- ISSN
2147-0634
- Publication type
Article
- DOI
10.5455/medscience.2024.02.014